Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Gold rises 0.6 % after hitting 14 month low briefly

    November 20, 2026

    Data centres could emit 40 million tonnes a year, report warns

    November 19, 2026

    Australians urged to pack emergency kits as El Niño builds

    November 18, 2026
    Auckland PostAuckland Post
    • Home
    • Contact Us
    • Disclaimer
    • Automotive

      Jaguar Type 01 electric GT debuts with 1,030 PS

      October 7, 2026

      Nissan tests AI-powered city navigation system in Japan

      September 22, 2025

      Ford recalls over 355000 trucks for dashboard display fault

      August 28, 2025

      EY finds 51500 auto jobs lost as German industry contracts

      August 26, 2025

      Lotus Evija becomes fastest electric car with 217 mph top speed

      August 18, 2025
    • Business

      Gold rises 0.6 % after hitting 14 month low briefly

      November 20, 2026

      Gold edges up to $4,043 as Fed hike bets cap rebound

      November 12, 2026

      OpenAI raises $11 billion at $1.25 trillion valuation

      November 9, 2026

      IEA says buildings can cut energy intensity 25% by 2035

      November 6, 2026

      Commonwealth Bank tips record 15% fall in home prices

      November 4, 2026
    • Entertainment

      Apple Arcade adds Jeopardy and NFL games in September update

      August 19, 2025

      Marvel’s Fantastic Four opens strong with 57 million dollars

      July 27, 2025

      Disney and Marvel’s R-rated film hits billion-dollar milestone

      August 17, 2024

      Web3 leader Immutable rolls out $50M gaming rewards initiative

      April 27, 2024

      USHER’s pre-Super Bowl experience on Apple Music

      February 7, 2024
    • Health

      WHO and INTERPOL Collaboration Aims to Enhance Global Public Health and Security for the Benefit of All

      October 17, 2026

      Mammal in mainland Australia benefits from first H5N1 bird flu detection

      August 24, 2026

      Australian Patients Could Benefit from New Approach to Triple-Negative Breast Cancer Treatment

      August 22, 2026

      Rabbit damage deepens across NSW Riverina

      March 16, 2026

      High-amylose wheat moves healthier white bread into stores

      March 16, 2026
    • Lifestyle

      JP Morgan funds Fresha with $31 million for AI and robotics growth

      August 23, 2024

      Adidas, Highsnobiety debut limited-edition sneakers

      January 6, 2024

      Unraveling Starbucks’ phenomenon as a worldwide coffee powerhouse

      September 1, 2023

      How Nike’s Kobe 8 Protro Halo Marks an Emotional Milestone

      August 29, 2023

      From labels to legacy – understanding fashion’s hierarchy

      August 21, 2023
    • Luxury

      Price hikes and lack of innovation erode luxury market confidence

      November 18, 2024

      Uncover the allure of Rolex Deepsea – luxury awaits.

      April 10, 2024

      Beyond timekeeping to the prestige of the Rolex Day-Date

      March 2, 2024

      Rare uncut emerald dazzles at Sharjah show

      February 1, 2024

      Porsche and Frauscher launch the electric 850 Fantom Air

      October 17, 2023
    • News

      Australians urged to pack emergency kits as El Niño builds

      November 18, 2026

      Minns pauses NSW underquoting laws as house prices fall

      November 17, 2026

      AFP warns minors make up 40% of counterterrorism cases

      November 13, 2026

      Cost of living tops Australian concerns in Scanlon survey

      November 5, 2026

      Family and Military Forces Gain from Mount Bundey Tragedy as Investigation Begins

      October 6, 2026
    • Sports

      Trump announces World Cup 2026 draw to be held in US capital

      August 23, 2025

      US Mexico Canada pledge coordinated response to drone risks in World Cup

      August 6, 2025

      Russian engineers launch AI robot for athletes’ training

      July 18, 2025

      Italy’s Jannik Sinner wins first Wimbledon men’s singles crown

      July 14, 2025

      Liverpool’s Salah earns top writers’ award for 2025

      May 9, 2025
    • Technology

      Data centres could emit 40 million tonnes a year, report warns

      November 19, 2026

      OECD finds large firms twice as likely to adopt AI

      November 6, 2026

      Apple iPhone Duo sets new benchmark for foldable phones

      November 2, 2026

      Apple iPhone Duo pairs foldable design with real trade-offs

      November 2, 2026

      Apple brings touch and tandem OLED to MacBook Pro

      October 29, 2026
    • Travel

      Travelers and Markets to Gain as Etihad Airways Boosts Australian Service with Increased Sydney Flights

      September 29, 2026

      Supporters to Benefit as Auckland 2027 State of Origin Date and Travel Packages Are Announced

      August 20, 2026

      Global aviation traffic expands in August despite headwinds

      October 1, 2025

      Spirit Airlines doubts future amid weak travel demand

      August 12, 2025

      Only travelers from high-risk nations targeted in US visa bond policy

      August 6, 2025
    Auckland PostAuckland Post
    Home » Australian Patients Could Benefit from New Approach to Triple-Negative Breast Cancer Treatment
    Health

    Australian Patients Could Benefit from New Approach to Triple-Negative Breast Cancer Treatment

    August 22, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    ADELAIDE, Australia / RankWire.AI / – Researchers in Australia have discovered a molecular switch that controls the spread of aggressive tumors. This finding offers a new potential pathway for therapy to prevent secondary cancers. Their study, published in EMBO Molecular Medicine, involves scientists from Adelaide University and the Olivia Newton-John Cancer Research Institute. They showed that restoring a key regulatory molecule called miR-342 can greatly reduce tumor metastasis. These results suggest a promising new strategy to combat triple-negative breast cancer by targeting dormant cancer cells before they form deadly secondary tumors in distant organs.

    Australian study opens new way to tackle triple-negative breast cancer
    Clinical research institutions develop precision oncology treatments for metastatic diseases.

    Triple-negative breast cancer makes up 10% to 15% of Australia’s roughly 21,000 annual breast cancer cases. It causes a higher number of deaths relative to its incidence. This subtype lacks estrogen, progesterone, and HER2 receptors, so standard hormone therapies do not work. The investigators found that when miR-342 levels decrease, a cancer-promoting pathway called E2F becomes overactive. This allows dormant cancer cells to spread and develop into dangerous secondary tumors.

    Targeted Treatments Bring New Hope for Preventing High-Risk Metastasis

    In laboratory models, scientists showed that raising miR-342 levels greatly reduced the spread of cancer to other organs. They also found that palbociclib, a CDK4/6 inhibitor approved for hormone receptor-positive breast cancers, significantly slowed metastatic tumor growth in models with low miR-342 levels. These results suggest that testing miR-342 could help doctors repurpose existing drugs to treat patients at high risk of metastasis.

    Associate Professor Philip Gregory from Adelaide University’s Centre for Cancer Biology, a co-senior author, said that preventing metastasis remains the biggest challenge in treating aggressive breast cancers. Gregory highlighted that because palbociclib targets the overactive E2F pathway, giving the drug after cancer spreads can stop microscopic deposits from growing. Instead of only shrinking primary tumors, this approach aims to prevent microscopic secondary cancers from becoming life-threatening.

    Pre-Clinical Results Published in Peer-Reviewed EMBO Molecular Medicine

    The research team pointed out that triple-negative breast cancer is biologically diverse. This diversity has made it difficult to develop universal targeted treatments. By identifying a specific weakness shared by a subgroup of patients, the study paves the way for personalized therapies. As Australian scientists look for new ways to fight triple-negative breast cancer, efforts are underway to validate these findings using patient-derived models before moving to clinical trials.

    Medical oncologists and cancer research groups across Australia welcomed these results. They emphasized the urgent need for more treatment options when primary therapies do not succeed. The team plans to work with international clinical networks to speed up biomarker screening. Validating miR-342 testing could soon help clinicians identify suitable candidates for targeted CDK4/6 inhibitor treatments early on, improving intervention outcomes.

    Related Posts

    WHO and INTERPOL Collaboration Aims to Enhance Global Public Health and Security for the Benefit of All

    October 17, 2026

    Mammal in mainland Australia benefits from first H5N1 bird flu detection

    August 24, 2026

    Rabbit damage deepens across NSW Riverina

    March 16, 2026

    High-amylose wheat moves healthier white bread into stores

    March 16, 2026

    McCain pulls cheese and bacon pizza pockets across Australia

    December 13, 2025

    Exercise-induced molecule Lac-Phe suppresses hunger

    October 7, 2025
    Latest News

    Gold rises 0.6 % after hitting 14 month low briefly

    November 20, 2026

    Data centres could emit 40 million tonnes a year, report warns

    November 19, 2026

    Australians urged to pack emergency kits as El Niño builds

    November 18, 2026

    Minns pauses NSW underquoting laws as house prices fall

    November 17, 2026

    AFP warns minors make up 40% of counterterrorism cases

    November 13, 2026

    Gold edges up to $4,043 as Fed hike bets cap rebound

    November 12, 2026
    © 2026 Auckland Post | All Rights Reserved
    • Home
    • Contact Us
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.